Results 231 to 240 of about 204,163 (273)
Some of the next articles are maybe not open access.
Supportive Care in Cancer, 1993
Severe neutropenia and its related infectious complications remain a permanent threat for patients receiving intensive chemotherapy, especially in the context of bone marrow transplantation. Chemoprophylaxis and use of colony-stimulating factors have altered the severity of the clinical picture in a favorable direction: neutropenia can be shortened ...
openaire +3 more sources
Severe neutropenia and its related infectious complications remain a permanent threat for patients receiving intensive chemotherapy, especially in the context of bone marrow transplantation. Chemoprophylaxis and use of colony-stimulating factors have altered the severity of the clinical picture in a favorable direction: neutropenia can be shortened ...
openaire +3 more sources
Expert Review of Anti-Infective Therapy, 2019
Introduction: Infections are among the most frequent complications in patients with hematological and oncological diseases. They might be classified as fever of unknown origin and microbiologically or clinically documented infections. Optimal duration of
M. Schmidt-Hieber +3 more
semanticscholar +1 more source
Introduction: Infections are among the most frequent complications in patients with hematological and oncological diseases. They might be classified as fever of unknown origin and microbiologically or clinically documented infections. Optimal duration of
M. Schmidt-Hieber +3 more
semanticscholar +1 more source
Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastim
Asia-Pacific Journal of Clinical Oncology, 2019Neutropenia is a common side effect of myelosuppressive chemotherapy. Administration of granulocyte colony‐stimulating factor is being used for neutropenia prophylaxis, but there are patients who develop neutropenia or febrile neutropenia despite ...
Mirinae Lee +6 more
semanticscholar +1 more source
Febrile Neutropenia in Children with Cancer: Approach to Diagnosis and Treatment.
Current pediatric reviews, 2018BACKGROUND Febrile neutropenia is one of the major acute side effects of intensive treatment in pediatric cancer, necessitating prompt initiation of empirical broad-spectrum antibiotics.
R. Kebudi, Hande Kızılocak
semanticscholar +1 more source
Brucellosis in febrile neutropenia
Leukemia & Lymphoma, 2007Neutropenia is the major factor predisposing cancer patients to infection, chiefly by bacteria. In neutropenic patients, antimicrobial or antifungal therapy should be instituted before the microbio...
Mehmet, Artac, Ramazan, Sari
openaire +2 more sources
Ceftriaxone in Febrile Neutropenia
Journal of Chemotherapy, 2003Standard management of febrile neutropenia requires prompt administration of empirical, broad-spectrum antibiotic therapy, since febrile neutropenia is associated with a significant risk of infectious complications and mortality. Risk-assessment models have been developed that differentiate febrile patients with neutropenia according to their risk for ...
M, Karthaus, O A, Cornely
openaire +2 more sources